ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae. It is meant to guide the consolidation of ECDC activities in relation to the molecular typing of multidrug-resistant pathogens and focus on the development of genomic typing-enhanced surveillance. It builds upon and synthesises evidence and the opinion of experts in Member States and at ECDC compiled since 2014.
The protocol was updated in July 2018 with minor changes to certain definitions and incorporates feedback received during a consultation with national technical coordinators at the inaugural meeting for the survey in November 2017.